Enuresis HP
Enuresis HP is an FDA drug label for the active ingredient ARGENTUM NITRICUM, BELLADONNA, CAUSTICUM, EQUISETUM HYEMALE, FERRUM PHOSPHORICUM, KREOSOTUM, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), THUJA OCCIDENTALIS, THYROIDINUM (SUIS) manufactured by Energique, Inc. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20230824.
Generic: ARGENTUM NITRICUM, BELLADONNA, CAUSTICUM, EQUISETUM HYEMALE, FERRUM PHOSPHORICUM, KREOSOTUM, NITRICUM ACIDUM, PULSATILLA (PRATENSIS), THUJA OCCIDENTALIS, THYROIDINUM (SUIS)
Manufacturer: Energique, Inc.
Product Type: HUMAN OTC DRUG
Route: ORAL
Dosage Form:
NDC: 44911-0153
Application:
Effective: 20230824
Active Ingredients: ACTIVE INGREDIENTS: (in each drop): 10.0% of Argentum Nitricum 30X, Belladonna 30X, Causticum 30X, Equisetum Hyemale 30X, Ferrum Phosphoricum 30X, Kreosotum 30X, Nitricum Acidum 30X, Pulsatilla 30X, Thuja Occidentalis 30X, Thyroidinum 30X.
Indications & Usage
INDICATIONS: May temporarily relieve symptoms due to bedwetting and abnormal bladder activity.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Dosage & Administration
DIRECTIONS: Adults and children 5 to 10 drops orally, 3 times daily or as otherwise directed by a health care professional. If symptoms persist for more than 7 days, consult your health care professional. Consult a physician for use in children under 12 years of age.
Contraindications
Not available.
Warnings
WARNINGS: If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place.
Adverse Reactions
Not available.
More from same ingredient
No related products.